ROIV
$35.72+0.62%
as of close, Oct 2, 2026
☾ AH $35.72 +0.62%
Roivant Sciences Ltd.Stock · Health CareNasdaq Composite 0.05%Russell 1000 0.02%US Stock Market 0.02%Russell 3000 0.02%
Roivant Sciences Ltd. returns by year
As of market close, Oct 2, 2026
Roivant Sciences Ltd. returns by year (2021–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $21.70 | $35.72 | 0.0% | +64.6% | |
| 2025 | $11.83 | $21.70 | 0.0% | +83.4% | |
| 2024 | $11.23 | $11.83 | 0.0% | +5.3% | |
| 2023 | $7.99 | $11.23 | 0.0% | +40.6% | |
| 2022 | $10.08 | $7.99 | 0.0% | -20.7% | |
| 2021 | $10.17 | $10.08 | 0.0% | -0.9% |
- Annualized
- +24.4%
- 2021–2026
- Average year
- +21.5%
- 5 full years
- Best year
- +83.4%
- 2025
- Worst year
- -20.7%
- 2022
- Positive years
- 3/5
- 60% up
Annualized (CAGR)
+24.4%
2021–2026
Average year
+21.5%
5 full years
Best year
+83.4%
2025
Worst year
-20.7%
2022
Positive years
3/5
60% up
Total return by period#
Annual
-50%0%50%
2021-0.89%'21
2022-21%'22
2023+41%'23
2024+5.3%'24
2025+83%'25
2026+65%'26
Methodology#
Total returns, dividends reinvested, measured on ROIV. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Roivant Sciences Ltd.'s average annual return?
- Since 2021, Roivant Sciences Ltd. (ROIV) has returned about 24.4% a year (the compound annual growth rate) and an average calendar-year return of 21.5%.
- What were Roivant Sciences Ltd.'s best and worst years?
- Over 2021–2026, the best year was 2025 (+83.4%) and the worst was 2022 (-20.7%).
- How often is Roivant Sciences Ltd. up in a year?
- 3 of the 5 full years since 2021 were positive — about 60% of the time.
More on Roivant Sciences Ltd.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100